PATENT CLAIM ANALYSIS

Application Number: 15984028
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "178000"]

Abstract:
Methods of treating a testosterone deficiency or its symptoms with a pharmaceutical formulation of testosterone esters are provided. The methods are designed to provide optimum plasma testosterone levels over an extended period.

Claim (Index 9):
The method of  claim 6 , wherein the dose of testosterone undecanoate in the administered oral pharmaceutical composition is decreased by about 10 mg to about 40 mg when the measured plasma testosterone concentration in the subject is greater than about 800 ng/dL.

Metadata:
- Claim Count in Document: 71.0
- Percentile: 93.0
- Lexical Diversity: 1.21429
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12758770', '13584958', '15107492', '15723985', '14691229']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8236245655151165
- 35 USC 102 Novelty (BERT): 0.5438424799184436
- Combined Prediction Score: 0.7956463569554493
- Mean Citation Score: 385.839508
- Max Citation Score: 404.2631
- Similarity Product: 240.99095765091184

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test